Page 63 - MI-2-1
P. 63

Microbes & Immunity                                       ABO blood type and cancer risk: A complex relationship



            54.  Engin H, Bilir C, Üstün H, Gökmen A. ABO blood group and   66.  Dede DS, Aksoy S, Dizdar O, et al. Blood ABO groups and
               risk of pancreatic cancer in a Turkish population in Western   risk of breast cancer. Med Oncol. 2010;27(4):1433.
               Blacksea region. Asian Pac J Cancer Prev. 2012;13(1):131-133.
                                                                  doi: 10.1007/s12032-009-9346-1
            55.  Li X, Xu H, Gao P. ABO Blood group and diabetes mellitus   67.  Klimant E, Glurich I, Mukesh B, Onitilo AA. Blood type,
               influence the risk for pancreatic cancer in a population from   hormone receptor status, HER2/neu status, and survival in
               China. Med Sci Monit. 2018;24:9392-9398.
                                                                  breast cancer: a retrospective study exploring relationships
               doi: 10.12659/MSM.913769                           in a phenotypically well-defined cohort.  Clin Med Res.
                                                                  2011;9(3-4):111-118.
            56.  Ateeb Z, Valente R, Pozzi-Mucelli RM, et al. Main pancreatic
               duct dilation greater than 6  mm is associated with an      doi: 10.3121/cmr.2011.907
               increased risk of high-grade dysplasia and cancer in IPMN   68.  Miao SY, Zhou W, Chen L, Wang S, Liu XA. Influence of
               patients. Langenbecks Arch Surg. 2019;404(1):31-37.
                                                                  ABO blood group and Rhesus factor on breast cancer risk:
               doi: 10.1007/s00423-018-1740-8                     A meta-analysis of 9665 breast cancer patients and 244,768
                                                                  controls. Asia Pac J Clin Oncol. 2014;10(2):101-108.
            57.  Gupta A, Saraiya V, Deveaux A, et al. Association of lipid
               profile biomarkers with breast cancer by molecular subtype:      doi: 10.1111/ajco.12083
               Analysis of the MEND study. Sci Rep. 2022;12(1):10631.
                                                               69.  Guleria K, Singh HP, Kaur H, Sambyal V. ABO blood groups
               doi: 10.1038/s41598-022-13740-x                    in gastrointestinal tract (GIT) and breast carcinoma patients.
                                                                  Anthropologist. 2005;7(3):189-192.
            58.  Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal
               A. Global cancer statistics 2018: GLOBOCAN estimates of      doi: 10.1080/09720073.2005.11890905
               incidence and mortality worldwide for 36 cancers in 185   70.  Mourali N, Muenz LR, Tabbane F, Belhassen S, Bahi J,
               countries. CA Cancer J Clin. 2018;68(6):394-424.
                                                                  Levine PH. Epidemiologic features of rapidly progressing
               doi: 10.3322/caac.21492                            breast cancer in Tunisia. Cancer. 1980;46(12):2741-2746.
            59.  Lei S, Zheng R, Zhang S,  et al. Global patterns of breast      doi:  10.1002/1097-0142(19801215)46:12<2741:aid-
               cancer incidence and mortality: A population-based cancer   cncr2820461234>3.0.co;2-w
               registry data analysis from 2000 to 2020. Cancer Commun.   71.  Gates  MA,  Wolpin  BM,  Cramer  DW,  Hankinson  SE,
               2021;41(11):1183-1194.
                                                                  Tworoger SS. ABO blood group and incidence of epithelial
               doi: 10.1002/cac2.12207                            ovarian cancer. Int J Cancer. 2011;128(2):482-486.
            60.  Saxena S, Chawla VK, Gupta KK, Gaur KL. Association of      doi: 10.1002/ijc.25339
               ABO blood group and breast cancer in Jodhpur. Indian J   72.  Zhang Y, Xu H, Pi S, Tan H, Huang B, Chen Y. The prognostic
               Physiol Pharmacol. 2015;59(1):63-68.
                                                                  and immunological role of FKBP1A in an integrated muti-
            61.  Singh K, Kote S, Patthi B,  et  al. Relative risk of various   omics cancers analysis, especially lung cancer. J Cancer Res
               head and neck cancers among different blood groups: An   Clin Oncol. 2023;149:16589-16608.
               analytical study. J Clin Diagn Res. 2014;8(4):ZC25-ZC28.
                                                                  doi: 10.1007/s00432-023-05362-1
               doi: 10.7860/JCDR/2014/7949.4244
                                                               73.  Yu J, Gao F, Klimberg VS, Margenthaler JA. ABO blood type/Rh
            62.  Urun Y, Utkan G, Altundag K, et al. ABO and Rh blood   factor and the incidence and outcomes for patients with triple-
               groups frequency in women with HER2 positive breast   negative breast cancer. Ann Surg Oncol. 2012;19(10):3159-3164.
               cancer. J BUON. 2012;17(3):457-460.
                                                                  doi: 10.1245/s10434-012-2533-x
            63.  Aly R, Yousef A. Association of ABO blood group and risk   74.  Amini M, Fatah SH, Kalantari M. ABO blood groups and
               of breast cancer. J Blood Disord Transfus. 2014;5(9):1000241.
                                                                  prognosis of breast cancer: A case-control study in Arak/
               doi: 10.4172/2155-9864.1000241                     Iran. Iran J Blood Cancer. 2012;4(2):61-65.
            64.  Flavarjani AH, Hedayatpour B, Bashardoost N, Nourian  SM.   75.  Majupuria KC, Gupta SR, Gupta LC. The study of ABO blood
               Study of the association between blood types and breast   groups and relationship with cancer breast (a preliminary
               cancer  among  Isfahanian  women  with  breast  cancer.  Adv   report). Indian J Cancer. 1966;3(3):182-183.
               Biomed Res. 2014;3:43.
                                                               76.  Costantini M, Fassio T, Canobbio L, Landucci M, Resasco M,
               doi: 10.4103/2277-9175.125749                      Boccardo F. Role of blood groups as prognostic factors in
                                                                  primary breast cancer. Oncology. 1990;47(4):308-312.
            65.  Meo SA, Suraya F, Jamil B, et al. Association of ABO and
               Rh  blood  groups  with  breast  cancer.  Saudi  J  Biol  Sci.      doi: 10.1159/000226839
               2017;24(7):1609-1613.
                                                               77.  Holdsworth PJ,  Thorogood J, Benson EA, Clayden AD.
               doi: 10.1016/j.sjbs.2017.01.058                    Blood group as a prognostic indicator in breast cancer. Br


            Volume 2 Issue 1 (2025)                         55                               doi: 10.36922/mi.3267
   58   59   60   61   62   63   64   65   66   67   68